⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Fremanezumab Effectiveness and Tolerability in Clinical Routine: Interim Real-world Data of the Observational FINESSE Study (P4-12.002)

Andreas Straube Gregor Brössner Xenia Hamann Charly Gaul Torsten Kraya Lars Neeb

View Full Paper

Ask AI

Bookmark

Share

Abstract

FINESSE aims to evaluate real-world effectiveness and tolerability of fremanezumab in adults with episodic (EM) or chronic migraine (CM).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Straube et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677d10 https://doi.org/10.1212/wnl.0000000000205838

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Long-term effectiveness of fremanezumab in episodic and chronic migraine patients in clinical routine : 24-months results from the prospective non-interventional FINESSE studyHuman Clinical Trial · 2026
26-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE) (P4-12.006)2024
3Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study2024 · 18 citations
4Fremanezumab for migraine in clinical practice: a systematic review and meta-analysisMeta-Analysis · 2026 · 1 citations
5Efficacy and Safety of Fremanezumab for the Preventive Treatment of Episodic and Chronic Migraine in Children and Adolescents: Outcomes from Two Randomized, Double-blind, Placebo-controlled, Phase 3 Studies (S37.003)Blinded Clinical Trial · 2026